Related Experiment Video

Updated: Aug 23, 2026

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
09:44

Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior

Published on: June 13, 2016

Chemokines in neoplastic progression

Albert Zlotnik1

  • 1Neurocrine Biosciences, 10555 Science Center Drive, San Diego, CA 92121, USA. azlotnik@neurocrine.com

Seminars in Cancer Biology
|July 13, 2004
PubMed

Insights

Targeting chemokine receptors like CXCR4 can inhibit cancer metastasis. This research highlights CXCR4/CXCL12 and CCR7/CCL21 as key therapeutic targets for controlling cancer spread to vital organs.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer metastasis, the spread of tumor cells, is a major cause of cancer mortality.
  • Chemokines and their receptors play a crucial role in regulating cancer cell migration.
  • Targeting these pathways offers a promising strategy for cancer treatment.

Purpose of the Study:

  • To identify key chemokine receptors and ligands involved in cancer metastasis.
  • To evaluate the therapeutic potential of targeting specific chemokine pathways.

Main Methods:

  • Literature review and analysis of existing data on chemokine receptor expression in various cancers.
  • Identification of frequently targeted chemokine receptor/ligand pairs.

Main Results:

  • CXCR4/CXCL12 and CCR7/CCL21 are identified as critical targets for metastasis.
  • CXCR4 is the most widely expressed chemokine receptor across different cancer types.
  • Targeting these systems may inhibit metastasis to lymph nodes, lungs, liver, bone marrow, and brain.

Conclusions:

  • Chemokine receptor-ligand interactions are crucial regulators of cancer cell migration.
  • CXCR4 and CCR7 represent significant therapeutic targets for controlling cancer metastasis.
  • Inhibition of CXCR4/CXCL12 and CCR7/CCL21 pathways holds promise for improving cancer patient outcomes.

More Related Videos

In vitro Cell Migration and Invasion Assays09:55

In vitro Cell Migration and Invasion Assays

Published on: June 1, 2014

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon towards...